# Maxcyte, Inc.: Form SCHEDULE 13D, filed May 14, 2026

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: SCHEDULE 13D
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 09:44 ET
- Period: not reported
- Accession: 0001486180-26-000002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000148618026000002/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000148618026000002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000148618026000002/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001486180-26-000002. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.